Peptide Cycling & Periodization Education

📚 Foundation Education Protocol

Back to Library
📚

Foundation Education

Peptide Cycling & Periodization Education

Foundational educational overview of how clinicians approach cycling and periodization of research compound programs

Low Risk ProfilebeginnerLow Evidence
Research Information

This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.

All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.

Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.

Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.

Overview

This foundational educational protocol explains the concepts of cycling, washout periods, and periodization as they apply to research compound programs. It is not a prescription for any specific cycle. The goal is to help individuals prepare informed questions for their clinician consultation.

Mechanism Summary

Cycling refers to planned on/off periods for research compounds to prevent receptor desensitisation, hormonal downregulation, and accumulation of side effects. GH secretagogues (CJC-1295, Ipamorelin) are often discussed in 3–6 month on / 1–2 month off frameworks in research contexts. Recovery peptides like BPC-157 may be used in shorter acute repair-focused windows. Periodization refers to aligning compound use with training or recovery phases. All specific parameters are clinician-determined.

Intended Goal

Understand how clinicians approach cycling, washout periods, and periodization before consulting a clinician about a research compound program

GH secretagogue / GHRH analogue

Used here as an example of a compound where cycling considerations are clinically relevant. Catalog reference.

Ipamorelin

View profile

GH secretagogue / ghrelin mimetic

Often paired with CJC-1295. Cycling considerations discussed in GH secretagogue context. Catalog reference.

Tissue repair / recovery

Example of a repair-focused compound where clinicians may discuss different cycling approaches vs. secretagogues. Catalog reference.

Protocol calculator: All compounds shown together. Set each vial size, BAC water added, and your intended dose — the draw units update instantly for every peptide in this protocol. Defaults are placeholders — adjust to your actual vials and clinician instructions.
CJC-1295GH secretagogue / GHRH analogue
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.
IpamorelinGH secretagogue / ghrelin mimetic
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.
BPC-157Tissue repair / recovery
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Who may be a candidate

  • Individuals new to research compounds preparing for a clinician consultation
  • Anyone seeking to understand what questions to ask a clinician about compound programs
  • Those who have read about cycling protocols online and want an educational framework

Exclusions

  • Not a template for self-directed cycling
  • Not a substitute for individualised clinician guidance
1

How do you approach cycling for GH secretagogues — what on/off schedule would you recommend for me?

2

How do you know when to add a washout period vs. continuing a compound?

3

Do recovery peptides like BPC-157 follow the same cycling principles as secretagogues?

4

How would you periodize a research compound program around my training or lifestyle?

5

What labs would you use to decide when to cycle off a compound?

Print or copy these questions using the "Copy Summary" button to bring to your appointment.

Legal & Compliance Notice

All compounds referenced are for educational context only. Regulatory status varies by jurisdiction. Verify with a licensed clinician.

The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.

This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.

Last reviewed: 2025-03-01 · Status: reviewed

Discuss with Your Clinician

Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.

Bring this protocol to your appointmentUse the questions below as a discussion guide